AxoGen, Inc. (AXGN) Revenue History
AxoGen, Inc. (AXGN) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $41.11M |
| 2017-12-31 | $60.43M |
| 2018-12-31 | $83.94M |
| 2019-12-31 | $106.71M |
| 2020-12-31 | $112.30M |
| 2021-12-31 | $127.36M |
| 2022-12-31 | $138.58M |
| 2023-12-31 | $159.01M |
| 2024-12-31 | $187.34M |
| 2025-12-31 | $225.21M |
How AXGN compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| HROW | Harrow Inc Com | $272.30M |
| IOVA | Iovance Biotherapeutics Inc. | $263.50M |
| AKBA | Akebia Therapeutics Inc. | $236.20M |
| CERS | Cerus Corporation | $233.80M |
| VNDA | Vanda Pharmaceuticals Inc. | $216.10M |
These are five companies in the same sector as AXGN with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get AxoGen, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AXGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AXGN | $50.40 | +8.53% | 1.78M |
| 3 | ||||
| 4 | ||||
| 5 |